High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

March 29, 2017

Primary Completion Date

April 21, 2023

Study Completion Date

April 21, 2023

Conditions
Colorectal CancerPancreatic CancerLung Cancer
Interventions
DRUG

Vitamin C

Vitamin C infusion will be administered intravenously at 1.25 g/kg for 4 days per week for 2-4 consecutive weeks (cohort A) or up to 6 months (cohort B). Cohort C will receive high dose vitamin C for 1-3 weeks. During week 1 vitamin C infusion and Y90 radioembolization of hepatic metastases will occur same day.

Trial Locations (2)

10065

Weill Cornell Medical College, New York

11215

New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn

All Listed Sponsors
collaborator

Stand Up To Cancer

OTHER

lead

Weill Medical College of Cornell University

OTHER

NCT03146962 - High Dose Vitamin C Intravenous Infusion in Patients With Resectable or Metastatic Solid Tumor Malignancies | Biotech Hunter | Biotech Hunter